MicroSummits

🚨 Back by Popular Demand… 🚨 We’re excited to bring back the mRNA Therapeutics MicroSummit — following an incredible debut last year, this session returns on May 14 with even more cutting-edge insights and breakthroughs! 🗓 Date & Time: May 14, 2025 | 1–2 PM Eastern / 10–11 AM Pacific If you're working on the next generation of RNA therapeutics, this is the place to be. Join leading scientists and translational minds advancing mRNA and beyond. What’s on the Agenda? 👉🏼 xRNA, Circular RNA & ON Innovations: Explore how novel formats and synthetic chemistries are redefining what’s possible in RNA-based drug development. 👉🏼 Delivery Gets Creative: Dive into new approaches to nanocarrier design — including science-fiction-inspired innovation — to overcome delivery bottlenecks. 👉🏼 Precision & Personalization: See how antisense oligos, mRNA vaccines, and brain-targeted RNA platforms are expanding the therapeutic reach of RNA. 👉🏼 Fixing the Fundamentals: Learn how teams are addressing manufacturing challenges, such as dsRNA impurities, to improve efficacy and safety at scale. And much more. 💡 Format & Networking: 55 minutes of curated talks + interactive discussions = maximum value in minimal time. Connect with key players and walk away with real insights. 🌐 Don’t Miss Out! Register below to join us and connect with innovators reshaping RNA science. #RNATherapeutics #mRNA #DrugDelivery #BiotechInnovation #NextGenTherapies #Oligonucleotides #RNAPlatforms

🚨 By Popular Demand… 🚨 We're thrilled to unveil the Radiopharma R&D MicroSummit - our latest addition and most requested series yet! 🗓 Date & Time: April 22, 2025 | 1–2 PM Eastern / 10–11 AM Pacific If you're working at the cutting edge of targeted cancer therapy, this is the one to watch. Join top scientists and translational experts shaping the future of radiopharmaceuticals. What’s on the Agenda? 👉🏼 Next-Gen Radionuclide Delivery: Explore how novel linker chemistry, nanobody platforms, and dendrimer-based systems are enhancing precision targeting and biodistribution. 👉🏼 Optimizing Combination Therapies: Discover how radiopharmaceuticals are being integrated with biologics and traditional oncology treatments to unlock synergistic effects. 👉🏼 Rethinking Dosimetry & Manufacturing: Learn how leaders are approaching personalized dosing, scale-up challenges, and the evolving infrastructure needed to support radiotheranostics at scale. And much more! Format & Networking: In just 55 minutes, enjoy lightning talks and interactive discussions that leave you with actionable insights and new connections in this fast-moving field. 🌐 Don’t Miss Out! Register below to join and network with the scientists and innovators shaping the next wave of radiopharmaceutical development. #Radiopharmaceuticals #Theranostics #OncologyInnovation #TargetedTherapy #DrugDevelopment

Last chance to engage with industry leaders exploring cutting-edge advancements in cell therapy innovation: Join us for the Final TCR and CAR-T MicroSummit to uncover the latest breakthroughs and connect with experts driving the field forward. 🗓 Date & Time: April 15, 2025 | 1-2 PM Eastern / 10-11 AM Pacific 🔎 What’s on the Agenda? 👉🏼 Targeting Solid Tumors: Discover novel strategies to overcome the challenges of the tumor microenvironment, featuring advancements in multi-specific T cells, gamma-delta T cell platforms, and engineered persistence for improved therapeutic outcomes. 👉🏼 Next-Generation CAR-T Engineering: Learn how innovative synthetic immune receptors are redefining CAR-T design to enhance cytotoxicity, optimize CD4/CD8 balance, and expand treatment options for solid tumor patients. 👉🏼 Off-the-Shelf Solutions: Explore breakthroughs in allogeneic, scalable T cell platforms designed to improve accessibility and extend cell therapies to a broader range of cancer indications. 💡 In just 55 minutes, gain insights from top innovators and uncover fresh collaboration opportunities to advance your cell therapy pipeline. 🌐 Don’t Miss Out! Register below to join the conversation and stay at the forefront of CAR-T and TCR innovation. #CellTherapy #Immunotherapy #DrugDevelopment #Biopharma #CARTInnovation

Excited – but a little sad. Our final session on Antibody-Drug Conjugates is officially set for March 25. This series has been packed with cutting-edge discussions, powerful connections, and insights from leading minds in ADCs. And we’re closing it out with a bang—expect fresh perspectives from experts at AbbVie, ImmuVia, and more. If you work in ADCs or targeted therapies, this is your last chance to be part of the conversation. Don’t miss it! 📅 March 25, 2025 | 1-2 PM ET / 10-11 AM PT 🔗 Register now to secure your spot! #ADC #TargetedTherapies #Biologics #DrugDevelopment #PrecisionMedicine

🌟 More Breakthroughs in Cell Therapy 🌟 As the next frontier in immunotherapy, CAR-T and TCR technologies are redefining how we tackle both hematologic and solid tumors—pushing the boundaries of innovation, improving efficacy, and expanding patient access. Join us for the CAR-T and TCR MicroSummit to explore the latest advancements and connect with R&D leaders pioneering the future of cell therapies. 🗓 Date & Time: March 11, 2025 | 1-2 PM Eastern / 10-11 AM Pacific 🔎 What’s on the Agenda? 👉🏼 Targeting Solid Tumors: Overcoming barriers in the tumor microenvironment, leveraging multi-specific and gamma-delta T cells, and enhancing persistence for greater efficacy in solid tumors. 👉🏼 Harnessing Cytotoxic T Cells: Engineering next-generation CAR-T and synthetic immune receptors to enhance cytotoxicity, optimize CD4/CD8 function, and widen the therapeutic window in clinical development. 👉🏼 Next-Generation Platforms: Advancements in off-the-shelf, allogeneic solutions and cutting-edge platforms designed to bring TCR and CAR-T therapies to broader patient populations. 💡 In just 55 minutes, hear from industry pioneers on breakthrough innovations in cell therapy. Expect lightning talks, interactive discussions, and new partnership opportunities with biopharma leaders. 🌐 Don’t Miss Out! Register below to connect with the experts shaping the next generation of CAR-T and TCR therapies. #CellTherapy #Immunotherapy #DrugDevelopment #Biopharma #CARTInnovation

🌟 Brand New MicroSummit Announced! 🌟 Join the AI in Drug Discovery MicroSummit 🗓 Date & Time: March 4, 2025 | 1-2 PM Eastern / 10-11 AM Pacific Open to drug developers, AI scientists, computational biologists, and biotech innovators: Connect in a focused, virtual setting dedicated to transforming drug discovery. What’s on the Agenda? 👉🏼 AI-Driven Molecule Discovery: Explore how AI is identifying novel drug candidates, predicting molecular interactions, and expanding the scope of chemical space beyond human capabilities. 👉🏼 From Data to Drugs: Learn how machine learning is revolutionizing target selection, structure-based drug design, and lead optimization, reducing time from concept to candidate. 👉🏼 Bridging Biology & AI: Discover how AI-powered visual biology and real-time data analysis are unlocking new therapeutic pathways and redefining early drug discovery. And much more! Format & Networking: In just 55 minutes, enjoy lightning talks and interactive discussions that will leave you with fresh insights and valuable industry connections. 🌐 Don’t Miss Out! Register below to join and network with the pioneers shaping the future of AI-driven drug discovery. #AIinDrugDiscovery #PharmaTech #Innovation #DrugDevelopment #PrecisionMedicine

Thank you for your feedback Cassian Yee! It's inspiring to see thought leaders like you embrace novel concepts of knowledge sharing and collaboration 🚀

🌟 Building on Another Great series – ADCs Take the Spotlight Again! 🌟 Our last ADC session was a tremendous success, bringing together top scientists and industry leaders for fast-paced, high-impact discussions. Here’s what attendees had to say: ✅ “GREAT speakers, well done! All were good.” – CEO ✅ “Again, another phenomenal session. Great speakers and topics. And very productive connections with the guests.” – Head of Translational Research ✅ “I enjoyed the session. I could hear the most recent advancements in ADCs and meet people from different backgrounds.” – Senior Scientist ✅ “It was great. Looking forward to continued discussion.” – VP of Research ✅ “Yes, very informative talks and great networking opportunity during the speed sessions.” – CSO ✅ “Another enjoyable session. A great learning opportunity connecting with leaders in the field and acquiring some of their knowledge.” – Principal Research Associate ✅ “Fascinating, got to meet a lot of people and introduce potential collaboration opportunities.” – Head of Discovery Chemistry Now, we’re keeping the momentum going! Join us for the next ADC session on February 18, 2025, as we dive deeper into the latest advances in this game-changing modality. 🗓 Date & Time: February 18, 2025 | 1-2 PM Eastern / 10-11 AM Pacific What to Expect: 🚀 More cutting-edge insights from industry leaders 🔬 High-impact discussions on ADC innovation 🤝 Fast-paced, productive networking If you’re working in ADCs or targeted therapies, you don’t want to miss this. Connect, collaborate, and stay ahead of the latest breakthroughs. 🌐 Register now to secure your spot! #TargetedTherapies #Biologics #DrugDevelopment #PrecisionMedicine #ADC

🌟 Continuing the Momentum in 2025 with Breakthroughs in CAR-T and TCR Therapies! 🌟 As the next frontier in immunotherapy, CAR-T and TCR technologies are revolutionizing how we treat both hematologic and solid tumors. Join us for the CAR-T and TCR MicroSummit to dive into the latest advancements and explore what’s next for these transformative modalities. 🗓 Date & Time: January 29, 2025 | 1-2 PM Eastern / 10-11 AM Pacific What’s on the Agenda? 👉🏼 Targeting Solid Tumors: Uncover strategies to enhance efficacy and overcome challenges in targeting solid tumors with CAR-T and TCR therapies. 👉🏼 Harnessing Cytotoxic T Cells: Learn about innovative approaches to developing cytotoxic CD4 T cells and their applications in solid and hematologic cancers. 👉🏼 Next-Generation Platforms: Explore the future of CAR-T and TCR development, including off-the-shelf solutions and novel constructs designed to maximize therapeutic potential. In just 55 minutes, experience lightning talks and interactive discussions with top minds in the field. Build your network, gain actionable insights, and stay at the forefront of cell therapy innovation. 🌐 Don’t Miss Out! Register below to connect with leaders shaping the future of CAR-T and TCR therapies. #CellTherapy #Immunotherapy #DrugDevelopment #Biopharma #CARTInnovation

🌟 Kicking Off the New Year with One of the Hottest Modalities – Antibody-Drug Conjugates! 🌟 From record-breaking acquisitions to exciting clinical approvals, ADCs continue to dominate the headlines as the next generation of precision therapies. Join us for the ADC MicroSummit, where we’ll dive into cutting-edge developments and explore what’s next for this powerful therapeutic modality. 🗓 Date & Time: January 21, 2025 | 1-2 PM Eastern / 10-11 AM Pacific What’s on the Agenda? 👉🏼 Expanding ADC Payload Horizons: Explore novel payload strategies, including kinase degraders, to overcome resistance and broaden ADC applications. 👉🏼 Precision-Driven Innovations: Discover advancements in tumor-selective linker and payload activation technologies, enhancing therapeutic efficacy and safety. 👉🏼 Next-Generation Designs: Learn about the future of ADCs, including bispecific ADCs and novel constructs pushing the boundaries of targeted drug delivery. In just 55 minutes, experience lightning talks and interactive discussions with leading R&D minds. Expand your network, gain actionable insights, and explore how ADCs are transforming precision medicine. 🌐 Don’t Miss Out! Register below to connect with innovators and experts driving ADC breakthroughs. #TargetedTherapies #Biopharma #DrugDevelopment #PrecisionMedicine #ADCInnovation